PH11211A - Antibiotic composition and method - Google Patents
Antibiotic composition and methodInfo
- Publication number
- PH11211A PH11211A PH13252A PH13252A PH11211A PH 11211 A PH11211 A PH 11211A PH 13252 A PH13252 A PH 13252A PH 13252 A PH13252 A PH 13252A PH 11211 A PH11211 A PH 11211A
- Authority
- PH
- Philippines
- Prior art keywords
- antibiotic composition
- antibiotic
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11310571A | 1971-02-05 | 1971-02-05 | |
US05/190,325 US3940483A (en) | 1971-02-05 | 1971-10-18 | Antibiotic compositions and method |
Publications (1)
Publication Number | Publication Date |
---|---|
PH11211A true PH11211A (en) | 1977-10-28 |
Family
ID=26810709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH13252A PH11211A (en) | 1971-02-05 | 1972-02-04 | Antibiotic composition and method |
Country Status (9)
Country | Link |
---|---|
US (1) | US3940483A (sv) |
AU (1) | AU463408B2 (sv) |
BE (1) | BE778999A (sv) |
CA (1) | CA982943A (sv) |
CH (1) | CH541969A (sv) |
DE (1) | DE2205272A1 (sv) |
ES (1) | ES399488A1 (sv) |
FR (1) | FR2124499B1 (sv) |
PH (1) | PH11211A (sv) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4001409A (en) * | 1975-05-23 | 1977-01-04 | Bristol-Myers Company | Injectable formulations of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid |
JPS5329936A (en) * | 1976-08-31 | 1978-03-20 | Takeda Chem Ind Ltd | Antibiotic composition |
US4235900A (en) * | 1978-11-15 | 1980-11-25 | E. R. Squibb & Sons, Inc. | Cephradine compositions |
FR2445833A1 (fr) * | 1979-01-04 | 1980-08-01 | Chimie Biolog | Nouveaux sels d'antibiotiques amines a cycle beta lactame |
IT1124610B (it) * | 1979-10-18 | 1986-05-07 | Zambo Spa | Mono(2-ammonio-2-idrossimetil-1,3-propandiolo) (2r-cis)-(o-metilossiranil)fosfonato |
ES525492A0 (es) * | 1982-09-10 | 1985-02-01 | Glaxo Group Ltd | Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama. |
KR890701104A (ko) * | 1987-05-27 | 1989-12-19 | 에지.지.제이.베르미렌, 에이.디.도우마 | β-락탐 항생제의 급용해성 무수 조성물 |
IE61679B1 (en) * | 1987-08-10 | 1994-11-16 | Fujisawa Pharmaceutical Co | Water-soluble antibiotic composition and water-soluble salts of new cephem compounds |
DE68922207T2 (de) * | 1989-02-06 | 1995-11-09 | Purzer Pharmaceutical Co | Verfahren zur Herstellung von Alkalimetall-Salze von 3,7-substituierten 7-Aminocephalosporansauerderivaten. |
CA2011365A1 (en) * | 1989-03-06 | 1990-09-06 | Eugene L. Inman | Diluent formulation for daptomycin |
US5721229A (en) * | 1995-12-26 | 1998-02-24 | Veterinary Pharmacy Corporation | Soluble forms of cephalosporins and treatment of animals |
US6225304B1 (en) | 1999-02-17 | 2001-05-01 | Pharmaceutical Solutions, Inc. | Soluble forms of amoxicillin and treatment of animals |
US6669929B1 (en) | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB895027A (en) * | 1959-08-03 | 1962-04-26 | Bristol Myers Co | Therapeutic tetracycline compositions |
US3136691A (en) * | 1962-03-05 | 1964-06-09 | Astra Pharma Prod | Aqueous solution of local anesthetic maintained under pressure |
GB1195203A (en) * | 1966-06-24 | 1970-06-17 | Glaxo Lab Ltd | Cephalosporins |
US3485819A (en) * | 1968-07-02 | 1969-12-23 | Squibb & Sons Inc | Alpha-amino-cyclohexadienylalkylene-penicillins and cephalosporins |
-
1971
- 1971-10-18 US US05/190,325 patent/US3940483A/en not_active Expired - Lifetime
-
1972
- 1972-01-27 CA CA133,297A patent/CA982943A/en not_active Expired
- 1972-02-04 PH PH13252A patent/PH11211A/en unknown
- 1972-02-04 AU AU38675/72A patent/AU463408B2/en not_active Expired
- 1972-02-04 BE BE778999A patent/BE778999A/xx not_active IP Right Cessation
- 1972-02-04 ES ES399488A patent/ES399488A1/es not_active Expired
- 1972-02-04 FR FR7203843A patent/FR2124499B1/fr not_active Expired
- 1972-02-04 CH CH163972A patent/CH541969A/fr not_active IP Right Cessation
- 1972-02-04 DE DE19722205272 patent/DE2205272A1/de active Pending
Also Published As
Publication number | Publication date |
---|---|
AU3867572A (en) | 1973-08-09 |
US3940483A (en) | 1976-02-24 |
FR2124499B1 (sv) | 1975-10-10 |
ES399488A1 (es) | 1977-05-16 |
AU463408B2 (en) | 1975-07-09 |
FR2124499A1 (sv) | 1972-09-22 |
DE2205272A1 (sv) | 1972-08-10 |
CH541969A (fr) | 1973-09-30 |
CA982943A (en) | 1976-02-03 |
BE778999A (fr) | 1972-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1001359A (en) | Blueing compositions and method | |
ZA726644B (en) | Sizing method and composition for use therein | |
PH11211A (en) | Antibiotic composition and method | |
CA963343A (en) | Dry-cleaning composition and method | |
CA999606A (en) | Concrete composition and method | |
ZA72580B (en) | Antibiotic compositions and method | |
KR780000396B1 (en) | Hub-platform assembly and loop-sizing method | |
CA986309A (en) | Explosive composition and method | |
AU5019272A (en) | Composition and process | |
AU4775772A (en) | Compositions and processes | |
HK28077A (en) | Antibiotic a-4696 | |
CA918839A (en) | Nylon composition and process therefor | |
PH11050A (en) | New antibiotic sf-1293 substance and its production | |
CA967985A (en) | Refractory-ceramic composition and method | |
CA987425A (en) | Polymeric composition and method | |
CA947235A (en) | Electrocoating process and composition | |
CA866743A (en) | Anthelmintic composition and method | |
CA884892A (en) | Composition and process | |
IL40151A0 (en) | Novel antibiotics and processes for their preparation | |
ZA728387B (en) | New antibiotic | |
CA857843A (en) | Metal-disintegrating composition and method | |
ZA71406B (en) | Decorative finish-producing composition and method | |
CA880873A (en) | Pharmaceutical composition and method | |
AU450641B2 (en) | Method and composition and rapid disinfection | |
CA882572A (en) | Grouting composition and method |